CD40 and prostate carcinoma: In line with this, the expression of many co-activating receptors was higher in normal prostate MNPs compared with those in prostate cancer, the exception being MAC-MT, which showed higher expression of a subset of co-activating receptors in tumor samples, including CD40 (Figures 5B and S7A).